88 FR 188 pgs. 67230-67231 - Foreign-Trade Zone (FTZ) 46, Notification of Proposed Production Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); Cincinnati, Ohio
Type: NOTICEVolume: 88Number: 188Pages: 67230 - 67231
Pages: 67230, 67231Docket number: [B-52-2023]
FR document: [FR Doc. 2023-21459 Filed 9-28-23; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-52-2023]
Foreign-Trade Zone (FTZ) 46, Notification of Proposed Production Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); Cincinnati, Ohio
Patheon Pharmaceuticals Inc. (Patheon) submitted a notification of proposed production activity to the FTZ Board (the Board) for its facilities in Cincinnati, Ohio, within Subzone 46K. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on September 18, 2023.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website-accessible via www.trade.gov/ftz. The proposed finished product(s) and material(s)/component(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board's website.
The proposed finished product is cancer treatment (active pharmaceutical ingredient-regorafenib) in finished dosage form (duty-free).
The proposed material/component is regorafenib active pharmaceutical ingredient (duty-free). The request indicates that the material/component is subject to duties under section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is November 8, 2023.
A copy of the notification will be available for public inspection in the "Online FTZ Information System" section of the Board's website.
FOR FURTHER INFORMATION, contact Diane Finver at Diane.Finver@trade.gov.
[top]
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-21459 Filed 9-28-23; 8:45 am]
BILLING CODE 3510-DS-P